Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Unusual Whales

Jul 28, 2026 at 12:06 PM

On July 28, 2026, Nautilus Biotechnology, Inc. (NASDAQ: NAUT) based in Seattle shared its financial outcomes for the quarter concluding on June 30, 2026. The company specializes in a cutting-edge single-molecule proteome analysis platform.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Nautilus Biotechnology

NAUT.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI